(1 - 33 von 50
)
Two years after IPO, a Lexington biotech shuts downThe Business Journals
AP — Markus Renschler, MD, is President & CEO of Cyteir The…utics, located in Lexington. Gary Higgins / Boston Business Journal. Rowan Walrath. By AP — Markus Renschler, MD, is President & CEO of Cyteir The…utics, located in Lexington. Gary Higgins / Boston Business Journal. Rowan Walrath. By ...
Association of Bioscience Financial Officers National ...FOX16.com
www.fox16.com
— Markus Renschler, MD, President and CEO of Cyteir The…utics; Meredith May, Award-winning journalist, fifth-generation beekeeper and best ...
... has the potential to broadly target multiple cancers with high levels of DNA damage induced by AID," said Markus Renschler, M.D., Cyteir president and CEO.
cyteir the…utics newsIJALR
... to be an all-oral treatment regimen for patients with platinum resistant ovarian cancer," said Markus Renschler, MD, Cyteirs President and CEO.
sortiert nach Relevanz / Datum